Post Chemotherapy Morphologic MR Imaging

  • Teresa Popolizio
  • Saverio Pollice
  • Tommaso Scarabino


Neurotoxicity of drugs is a pathologic condition which is on the rise due to both the wider use of specific antiblastic therapies and the improved clinical and neuroradiologic performance that allow early and specific diagnosis.


Posterior Reversible Encephalopathy Syndrome Subcortical White Matter Signal Hyperintensity MGMT Gene Neuroradiologic Finding 


  1. 1.
    Brandes AA, Franceschi E, Tosoni A et al (2008) MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radio-chemiotherapy in newly diagnosed glioblastoma patients. J Clin Oncol 26:2192-2197PubMedCrossRefGoogle Scholar
  2. 2.
    Brandsma D, Stalpers L, Taal et al (2008) Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 9:453-461PubMedCrossRefGoogle Scholar
  3. 3.
    Sanghera P, Perry J, Sahgal A et al (2010) Pseudoprogression following chemoradiotherapy for glioblastoma multiforme. Can J Neurol Sci 37:36-42PubMedGoogle Scholar
  4. 4.
    Stupp R, Hegi M (2007) Methylguanine methyltransferase testing in glioblastoma: when and how? J Clin Oncol 25:1459-1460PubMedCrossRefGoogle Scholar
  5. 5.
    Macdonald DR, Cascino TL, Schold SC et al (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277-1280PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  • Teresa Popolizio
    • 1
  • Saverio Pollice
  • Tommaso Scarabino
  1. 1.Department of NeuroradiologyScientific Institute “Casa Sollievo della Sofferenza”San Giovanni Rotondo (FG)Italy

Personalised recommendations